Jean-Paul Borg

发表

Response to “Problems with LAP nomenclature”

Norbert Perrimon, Daniel Birnbaum, Michel Labouesse, 2001, Nature Cell Biology.

Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2–JNK signalling in breast cancer

Daniel Birnbaum, Marc Lopez, Terje Johansen, 2016, Nature Communications.

Biochemical studies and molecular dynamics simulations of Smad3-Erbin interaction identify a non-classical Erbin PDZ binding.

Matthieu Chavent, Bernard Maigret, Jean-Paul Borg, 2009, Biochemical and biophysical research communications.

A serum protein signature with high diagnostic value in bacterial endocarditis: results from a study based on surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

Gilbert Habib, Jean-Paul Borg, Didier Raoult, 2006, The Journal of infectious diseases.

Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis

Daniel Birnbaum, Jean-Paul Borg, Pascal Finetti, 2011, Breast Cancer Research and Treatment.

Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer

Lydie Lane, Daniel Birnbaum, Jean-Paul Borg, 2011, PloS one.

Identification of new mechanisms of cellular response to chemotherapy by tracking changes in post-translational modifications by ubiquitin and ubiquitin-like proteins.

Jean-Paul Borg, Maxime Garcia, Thomas Bonacci, 2014, Journal of proteome research.

Interaction between Erbin and a Catenin-related Protein in Epithelial Cells*

Daniel Birnbaum, Jean-Paul Borg, D. Birnbaum, 2002, The Journal of Biological Chemistry.

PDZ Domain Proteins: Plug and Play!

Seth G. N. Grant, Jean-Paul Borg, S. Grant, 2003, Science's STKE.

Quantifying domain-ligand affinities and specificities by high-throughput holdup assay

Renaud Vincentelli, Katja Luck, Gilles Travé, 2015, Nature Methods.